Sabal Trust’s Bristol-Myers Squibb BMY Stock Holding History

Sabal Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,028	Closed	-$292K	–	219
2023 Q3	$292K	Sell	5,028 -875	-15%	-$53.6K	0.02%	172
2023 Q2	$377K	Sell	5,903 -277	-4%	-$18.6K	0.02%	159
2023 Q1	$428K	Sell	6,180 -1,667	-21%	-$118K	0.03%	102
2022 Q4	$565K	Sell	7,847 -127	-2%	-$9.58K	0.04%	92
2022 Q3	$567K	Buy	7,974 +392	+5%	+$28.4K	0.04%	93
2022 Q2	$584K	Buy	7,582 +159	+2%	+$12.1K	0.04%	90
2022 Q1	$542K	Sell	7,423 -7,144	-49%	-$480K	0.04%	90
2021 Q4	$908K	Sell	14,567 -295,975	-95%	-$17.4M	0.06%	82
2021 Q3	$18.4M	Buy	310,542 +10,895	+4%	+$718K	1.31%	44
2021 Q2	$20M	Buy	299,647 +12,669	+4%	+$826K	1.44%	40
2021 Q1	$18.1M	Buy	286,978 +18,748	+7%	+$1.17M	1.35%	43
2020 Q4	$16.6M	Buy	268,230 +22,884	+9%	+$1.41M	1.34%	41
2020 Q3	$14.8M	Buy	245,346 +8,833	+4%	+$532K	1.29%	40
2020 Q2	$13.9M	Buy	236,513 +226,347	+2,227%	+$13.5M	1.3%	40
2020 Q1	$567K	Sell	10,166 -4,200	-29%	-$257K	0.06%	78
2019 Q4	$922K	Buy	14,366 +50	+0.3%	+$2.86K	0.07%	76
2019 Q3	$726K	Buy	14,316 +5,441	+61%	+$256K	0.06%	83
2019 Q2	$402K	Sell	8,875 -1,057	-11%	-$49.2K	0.04%	94
2019 Q1	$474K	Sell	9,932 -1,895	-16%	-$94.4K	0.04%	95
2018 Q4	$615K	Buy	11,827 +805	+7%	+$43.3K	0.06%	86
2018 Q3	$685K	Sell	11,022 -7,550	-41%	-$448K	0.06%	84
2018 Q2	$1.03M	Sell	18,572 -410,088	-96%	-$22.1M	0.1%	71
2018 Q1	$27.1M	Buy	428,660 +99	+0%	+$6.37K	2.59%	11
2017 Q4	$26.3M	Buy	428,561 +6,615	+2%	+$414K	2.68%	20
2017 Q3	$26.9M	Buy	421,946 +412,830	+4,529%	+$24.1M	2.69%	11
2017 Q2	$507K	Buy	9,116 +451	+5%	+$24.5K	0.05%	85
2017 Q1	$471K	Buy	8,665 +3,800	+78%	+$208K	0.05%	84
2016 Q4	$284K	Sell	4,865 -2,822	-37%	-$154K	0.03%	101
2016 Q3	$414K	Buy	7,687 +1,152	+18%	+$74K	0.05%	88
2016 Q2	$481K	Buy	6,535 +2,545	+64%	+$180K	0.06%	75
2016 Q1	$255K	Sell	3,990 -400	-9%	-$25.2K	0.03%	105
2015 Q4	$302K	Hold	4,390	–	–	0.04%	95
2015 Q3	$260K	Sell	4,390 -100	-2%	-$6.34K	0.04%	92
2015 Q2	$299K	Buy	4,490 +100	+2%	+$6.59K	0.04%	89
2015 Q1	$283K	Sell	4,390 -1,001	-19%	-$62.7K	0.04%	91
2014 Q4	$318K	Sell	5,391 -300	-5%	-$16.9K	0.04%	91
2014 Q3	$291K	Buy	5,691 +214	+4%	+$10.7K	0.04%	93
2014 Q2	$265K	Sell	5,477 -569	-9%	-$28K	0.04%	93
2014 Q1	$314K	Buy	6,046 +1,301	+27%	+$69.2K	0.04%	88
2013 Q4	$253K	Hold	4,745	–	–	0.04%	101
2013 Q3	$219K	Hold	4,745	–	–	0.03%	102
2013 Q2	$212K	Buy	+4,745	New	+$206K	0.03%	102

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sabal Trust's BMY Position: Q4 2023 in Review

Sabal Trust sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 5,028 shares — an estimated $292K sold.

Sabal Trust first reported a position in BMY in Q2 2013 and held it in 42 quarters. The position peaked at $27.1M in Q1 2018. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Sabal Trust reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Sabal Trust sold 5,028 Bristol-Myers Squibb shares in Q4 2023, an estimated $292K.
Sabal Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 42 quarters.
Sabal Trust's Bristol-Myers Squibb position peaked at $27.1M in Q1 2018.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Sabal Trust's 13F filing for Q4 2023, filed 25 Jan 2024.